Researchers are now exploring strategies to silence cccDNA, aiming for a functional cure and offering hope to millions of patients worldwide. Hepatitis B virus infection remains one of the leading ...

People fully vaccinated against hepatitis B who are not immunocompromised can expect sustained immunity throughout their ...

Claim construction hearing for Pfizer/BioNTech mRNA-LNP vaccine litigation occurred in December 2024; outcome pending Jury trial in Moderna U.S.

Scientists from the Institut Pasteur, in collaboration with Kumamoto University in Japan, have assessed a new rapid ...

Two oral presentations will highlight the continued potent antiviral activity of ALG-000184 for chronic hepatitis B virus (HBV) infection in both HBeAg-positive and HBeAg-negative subjects, ...

Hepatitis B is a liver infection caused by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Analysts at William Blair have suggested that the market for an HBV cure could be around the same size as for hepatitis C virus, which peaked at around $10 billion a year but was a short-lived ...

Hepatitis B is a liver infection cause by the hepatitis B virus (HBV), and long-term hepatitis B infections that last longer ...

Health care workers are at higher risk of hepatitis B infection due to occupational exposure to blood and body fluids.

Analysts at William Blair have suggested that the market for an HBV cure could be around the same size as for hepatitis C virus, which peaked at around $10 billion a year, but was a short-lived ...

Researchers are now exploring strategies to silence cccDNA, aiming for a functional cure and offering hope to millions of patients worldwide. Hepatitis B virus infection remains one of the leading ...